Abbvie Randd
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Extensive global R&D infrastructure with 9 centers and over 15,000 scientists and staff, significant annual investment ($13.8 billion in 2025), and a focus on leveraging cutting-edge technologies like AI to accelerate discovery and improve patient outcomes.
Description Brand's website · 2026-10-04
The research & development division of AbbVie, focused on discovering and advancing innovative therapies for complex diseases across immunology, oncology, neuroscience, eye care, and aesthetics. It emphasizes scientific progress, relentless refinement, and global collaboration to transform patient outcomes.
Offerings
Core capabilities Brand's website · 2026-10-04
- Research and development efforts leading to compounds
- devices
- and indications in development across six therapeutic areas
- including immunology
- oncology
- neuroscience
- eye care
- and aesthetics.
Pricing Brand's website · 2026-10-04
Not applicable, as it is an internal R&D division of a pharmaceutical company, funded through corporate investment.
Audience
Target industry Brand's website · 2026-10-04
Global patients and healthcare systems, aiming to address unmet medical needs through pioneering scientific advancements.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Abbvie Randd's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Abbvie Randd across the index.
Claim Abbvie Randd — free →Page last updated 2026-10-17.